TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

10681	Companies
228020	Keywords
156520	Articles
120879	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 06/01/2025 at 19:15, 1 year 1 month ago

Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
Transgene and NEC reveal positive data on TG4050 cancer vaccine, demonstrating durable disease-free survival and sustained T cell responses at 24 months in HPV-negative head and neck cancer. Conference call on June 6, 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 NEC
BRIEF

published on 05/22/2025 at 17:50, 1 year 1 month ago

Transgene to Present Phase I Data on Cancer Vaccine TG4050 at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Phase I Data
BRIEF

published on 05/22/2025 at 17:50, 1 year 1 month ago

Transgene présentera les données de phase I sur le vaccin contre le cancer TG4050 à l'ASCO 2025

Vaccin Contre Le Cancer Transgene TG4050 ASCO 2025 Données De La Phase I
PRESS RELEASE

published on 05/22/2025 at 17:45, 1 year 1 month ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
BRIEF

published on 04/10/2025 at 20:20, 1 year 2 months ago

Mise à disposition du Document d’Enregistrement Universel 2024 par Transgene

AMF Immunothérapie Responsabilité Sociale Document D'enregistrement Transgene
BRIEF

published on 04/10/2025 at 20:20, 1 year 2 months ago

Transgene makes available the 2024 Universal Registration Document

AMF Social Responsibility Immunotherapy Registration Document Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 2 months ago

Mise à disposition du Document d’Enregistrement Universel (DEU) 2024 de Transgene
Transgene annonce la mise à disposition de son Document d'Enregistrement Universel 2024 auprès de l'AMF, contenant des informations financières et RSE

AMF RSE Informations Financières Document D'Enregistrement Universel Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 2 months ago

Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene announces availability of its 2024 Universal Registration Document (URD) containing financial reports and ESG factors. French & English versions can be accessed online

Financial Reports Transgene ESG Factors 2024 Universal Registration Document French Version
BRIEF

published on 03/27/2025 at 17:50, 1 year 3 months ago

Transgene : avancées majeures et perspectives 2025

Immunothérapie Cancer De La Tête Et Du Cou Résultats Financiers 2024 Vaccin TG4050 Plateforme Myvac®
BRIEF

published on 03/27/2025 at 17:50, 1 year 3 months ago

Transgene: major advances and outlook for 2025

Immunotherapy Head And Neck Cancer 2024 Financial Results TG4050 Vaccine Myvac® Platform

Accesswire

Published on 07/03/2026 at 23:00, 1 day 16 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 1 day 16 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 1 day 17 hours ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 19 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days 1 hour ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/05/2026 at 13:45, 1 hour 29 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 1 hour 29 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 21 hours 38 minutes ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 4 hours ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 6 hours ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

Les Echos

Published on 07/03/2026 at 21:49, 1 day 17 hours ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day 17 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 20 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 1 day 20 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 1 day 20 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE